study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MH-PROBIO-AXIS_01,2012,randomized controlled trial,SMD,-0.3004,-0.4524,-0.1484,62,53,some concerns,10.1234/mh-probio-axis-01,mental_health_journal,gut_brain_axis,Adults with gut brain axis concerns,Mild GI discomfort,10
MH-PROBIO-AXIS_02,2013,randomized controlled trial,SMD,-0.3591,-0.5115,-0.2066,66,56,mixed,10.1234/mh-probio-axis-02,mental_health_journal,gut_brain_axis,Adults with gut brain axis concerns,Transient headache,11
MH-PROBIO-AXIS_03,2014,randomized controlled trial,SMD,-0.4477,-0.6071,-0.2884,70,59,low,10.1234/mh-probio-axis-03,mental_health_journal,gut_brain_axis,Adults with gut brain axis concerns,None reported,6
